Literature DB >> 9277012

Control of Schistosoma haematobium morbidity on Pemba Island: validity and efficiency of indirect screening tests.

N J Lwambo1, L Savioli, U M Kisumku, K S Alawi, D A Bundy.   

Abstract

Four indirect screening methods for the detection of Schistosoma haematobium morbidity are compared (history of haematuria, visual haematuria, and microhaematuria at the 1+ and 2+ positivity limit by reagent strips) in terms of their diagnostic performance under conditions of progressive decrease in prevalence of infection, intensity and risk of morbidity as a result of repeated schistosomiasis control programmes on Pemba Island, United Republic of Tanzania. The results show that the sensitivity of a history of haematuria was higher (71%) in children but lower in adults (40%), similar to the findings for visual haematuria in children (60%) and adults (40%) at baseline. However, visual haematuria had a higher specificity, positive predictive value, and efficiency than a history of haematuria in both children and adults. Microhaematuria at the 1+ positivity limit (by reagent strips) had the highest sensitivity of all the methods investigated, but the lowest specificity, positive predictive value, and efficiency. Quantitatively, the indirect methods tended to increase in specificity, negative predictive value, and efficiency during the course of the intervention programme. In contrast, positive predictive value tended to decrease, while the sensitivity remained fairly stable. Overall, these findings suggest that a history of haematuria and/or visual haematuria are appropriate methods for preliminary screening of communities to identify those at risk of morbidity. Thereafter, microhaematuria (1+ positivity limit) may be the more appropriate method for targeting intervention at the individual level.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9277012      PMCID: PMC2486950     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  8 in total

1.  Control of morbidity due to Schistosoma haematobium on Pemba Island: egg excretion and hematuria as indicators of infection.

Authors:  L Savioli; C Hatz; H Dixon; U M Kisumku; K E Mott
Journal:  Am J Trop Med Hyg       Date:  1990-09       Impact factor: 2.345

2.  Urinary schistosomiasis: influence of the circadian variation of hematuria and proteinuria on reagent stick testing.

Authors:  C Lengeler; S Komba; D Morona
Journal:  Acta Trop       Date:  1991-02       Impact factor: 3.112

3.  Community-based questionnaires and health statistics as tools for the cost-efficient identification of communities at risk of urinary schistosomiasis.

Authors:  C Lengeler; D de Savigny; H Mshinda; C Mayombana; S Tayari; C Hatz; A Degrémont; M Tanner
Journal:  Int J Epidemiol       Date:  1991-09       Impact factor: 7.196

4.  Control of morbidity due to Schistosoma haematobium on Pemba Island: programme organization and management.

Authors:  L Savioli; H Dixon; U M Kisumku; K E Mott
Journal:  Trop Med Parasitol       Date:  1989-06

Review 5.  Measurement of schistosomiasis-related morbidity at community level in areas of different endemicity.

Authors:  C Hatz; L Savioli; C Mayombana; J Dhunputh; U M Kisumku; M Tanner
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

6.  Control of morbidity due to Schistosoma haematobium on Pemba island; selective population chemotherapy of schoolchildren with haematuria to identify high-risk localities.

Authors:  L Savioli; H Dixon; U M Kisumku; K E Mott
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 Nov-Dec       Impact factor: 2.184

7.  Urinary schistosomiasis on Pemba Island: low-cost diagnosis for control in a primary health care setting.

Authors:  L Savioli; K E Mott
Journal:  Parasitol Today       Date:  1989-10

8.  Chemotherapy-based control of schistosomiasis haematobia. I. Metrifonate versus praziquantel in control of intensity and prevalence of infection.

Authors:  C H King; G Lombardi; C Lombardi; R Greenblatt; S Hodder; H Kinyanjui; J Ouma; O Odiambo; P J Bryan; J Muruka
Journal:  Am J Trop Med Hyg       Date:  1988-09       Impact factor: 2.345

  8 in total
  11 in total

Review 1.  Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas.

Authors:  Eleanor A Ochodo; Gowri Gopalakrishna; Bea Spek; Johannes B Reitsma; Lisette van Lieshout; Katja Polman; Poppy Lamberton; Patrick M M Bossuyt; Mariska M G Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2015-03-11

2.  Urine heme dipsticks are useful in monitoring the impact of praziquantel treatment on Schistosoma haematobium in sentinel communities of Delta State, Nigeria.

Authors:  Emmanuel Emukah; Julie Gutman; John Eguagie; Emmanuel S Miri; Paul Yinkore; Ndudi Okocha; Victoria Jibunor; Obiageli Nebe; Augustine Ikenna Nwoye; Frank O Richards
Journal:  Acta Trop       Date:  2012-01-08       Impact factor: 3.112

3.  Epidemiology of malaria, schistosomiasis, geohelminths, anemia and malnutrition in the context of a demographic surveillance system in northern Angola.

Authors:  José Carlos Sousa-Figueiredo; Dina Gamboa; João Mário Pedro; Cláudia Fançony; António Justino Langa; Ricardo J Soares Magalhães; J Russell Stothard; Susana Vaz Nery
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

4.  Epidemiology of Schistosomiasis and Usefulness of Indirect Diagnostic Tests in School-Age Children in Cubal, Central Angola.

Authors:  Cristina Bocanegra; Sara Gallego; Jacobo Mendioroz; Milagros Moreno; Elena Sulleiro; Fernando Salvador; Nicolau Sikaleta; Arlette Nindia; Daniel Tchipita; Morais Joromba; Sebastiao Kavaya; Adrián Sánchez Montalvá; Teresa López; Israel Molina
Journal:  PLoS Negl Trop Dis       Date:  2015-10-16

5.  Infection and co-infection with helminths and Plasmodium among school children in Côte d'Ivoire: results from a National Cross-Sectional Survey.

Authors:  Richard B Yapi; Eveline Hürlimann; Clarisse A Houngbedji; Prisca B Ndri; Kigbafori D Silué; Gotianwa Soro; Ferdinand N Kouamé; Penelope Vounatsou; Thomas Fürst; Eliézer K N'Goran; Jürg Utzinger; Giovanna Raso
Journal:  PLoS Negl Trop Dis       Date:  2014-06-05

6.  Epidemiological and clinical aspects of urogenital schistosomiasis in women, in Burkina Faso, West Africa.

Authors:  Adama Zida; Janika Briegel; Ibrahim Kabré; Marcel P Sawadogo; Ibrahim Sangaré; Sanata Bamba; Abdourahamane Yacouba; Amado Ouédraogo; Dieudonné Yonli; François Drabo; Lady Kady Traoré; Ramata Ouédraogo-Traoré; Robert Tinga Guiguemdé; Jürgen Wacker
Journal:  Infect Dis Poverty       Date:  2016-09-01       Impact factor: 4.520

7.  "We know about schistosomiasis but we know nothing about FGS": A qualitative assessment of knowledge gaps about female genital schistosomiasis among communities living in Schistosoma haematobium endemic districts of Zanzibar and Northwestern Tanzania.

Authors:  Humphrey D Mazigo; Anna Samson; Valencia J Lambert; Agnes L Kosia; Deogratias D Ngoma; Rachel Murphy; Dunstan J Matungwa
Journal:  PLoS Negl Trop Dis       Date:  2021-09-30

8.  Measuring morbidity associated with urinary schistosomiasis: assessing levels of excreted urine albumin and urinary tract pathologies.

Authors:  José C Sousa-Figueiredo; María-Gloria Basáñez; I Simba Khamis; Amadou Garba; David Rollinson; J Russell Stothard
Journal:  PLoS Negl Trop Dis       Date:  2009-10-06

Review 9.  Epidemiology and control of human schistosomiasis in Tanzania.

Authors:  Humphrey D Mazigo; Fred Nuwaha; Safari M Kinung'hi; Domenica Morona; Angela Pinot de Moira; Shona Wilson; Jorg Heukelbach; David W Dunne
Journal:  Parasit Vectors       Date:  2012-11-28       Impact factor: 3.876

10.  Diagnostic performance of Schistosoma real-time PCR in urine samples from Kenyan children infected with Schistosoma haematobium: day-to-day variation and follow-up after praziquantel treatment.

Authors:  Natalie V S Vinkeles Melchers; Govert J van Dam; David Shaproski; Anthony I Kahama; Eric A T Brienen; Birgitte J Vennervald; Lisette van Lieshout
Journal:  PLoS Negl Trop Dis       Date:  2014-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.